NCT00998751View on ClinicalTrials.gov

Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Gastro-intestinal Stromal Tumours
Interventions
DRUG

oral masitinib

7.5 mg/kg/day

Trial Locations (1)

Unknown

Lecesne, Villejuif

Sponsors

Lead Sponsor

AB Science
All Listed Sponsors
lead

AB Science

INDUSTRY